BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+5.07%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$1.97T
AUM Growth
+$93.4B
(+5%)
Cap. Flow
+$16.2B
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
12.83%
Holding
5,103
New
99
Increased
2,901
Reduced
1,388
Closed
150
Top Buys
| 1 |
DuPont de Nemours
DD
|
+$4.96B |
| 2 |
Microsoft
MSFT
|
+$1.39B |
| 3 |
Baker Hughes
BKR
|
+$1.07B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$837M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$649M |
Top Sells
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$4.45B |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$3.31B |
| 3 |
BHI
Baker Hughes
BHI
|
+$1.63B |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$847M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$794M |
Sector Composition
| 1 | Financials | 15.27% |
| 2 | Technology | 14.6% |
| 3 | Healthcare | 13.58% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Radware
RDWR
$1.1B
| $5.54M | ﹤0.01% |
328,636
+5,220
| +2% | +$88K |
|
3377
Pure Cycle
PCYO
$265M
| $5.53M | ﹤0.01% |
737,948
+13,261
| +2% | +$99.4K |
|
3378
Magna International
MGA
$13.1B
| $5.43M | ﹤0.01% |
101,820
+101,812
| +1,272,650% | +$5.43M |
|
|
ATNX
3379
DELISTED
Athenex, Inc. Common Stock
ATNX
| $5.39M | ﹤0.01% |
+15,395
| New | +$5.39M |
|
3380
Goldman Sachs BDC
GSBD
$1.3B
| $5.38M | ﹤0.01% |
235,904
-9,527
| -4% | -$217K |
|
3381
Methanex
MEOH
$3.04B
| $5.36M | ﹤0.01% |
106,586
+59,521
| +126% | +$2.99M |
|
3382
iShares MSCI China A ETF
CNYA
$217M
| $5.34M | ﹤0.01% |
175,000
-85,000
| -33% | -$2.59M |
|
|
BCRH
3383
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $5.32M | ﹤0.01% |
323,615
+1,371
| +0.4% | +$22.6K |
|
3384
Unilever
UL
$154B
| $5.32M | ﹤0.01% |
91,779
+52,683
| +135% | +$3.05M |
|
|
SPNE
3385
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $5.3M | ﹤0.01% |
472,535
+34,196
| +8% | +$384K |
|
|
ROX
3386
DELISTED
Castle Brands, Inc.
ROX
| $5.25M | ﹤0.01% |
3,919,549
+118,992
| +3% | +$159K |
|
|
BBOX
3387
DELISTED
Black Box Corp
BBOX
| $5.24M | ﹤0.01% |
1,611,133
+21,471
| +1% | +$69.8K |
|
3388
Middlefield Banc Corp
MBCN
$245M
| $5.23M | ﹤0.01% |
227,008
+3,260
| +1% | +$75.1K |
|
3389
iShares ESG Advanced High Yield Corporate Bond ETF
HYXF
$185M
| $5.21M | ﹤0.01% |
100,000
| – | – |
|
3390
iShares MSCI Emerging Markets ex China ETF
EMXC
$13.1B
| $5.1M | ﹤0.01% |
+100,000
| New | +$5.1M |
|
|
ENLC
3391
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $5.1M | ﹤0.01% |
295,538
+68,439
| +30% | +$1.18M |
|
|
ISRL
3392
DELISTED
Isramco Inc
ISRL
| $5.1M | ﹤0.01% |
43,930
+737
| +2% | +$85.5K |
|
|
OPOF
3393
DELISTED
Old Point Financial
OPOF
| $5.03M | ﹤0.01% |
155,400
+1,817
| +1% | +$58.9K |
|
3394
Viridian Therapeutics
VRDN
$1.54B
| $5.03M | ﹤0.01% |
36,614
+2,225
| +6% | +$305K |
|
3395
Nature's Sunshine
NATR
$299M
| $5.02M | ﹤0.01% |
494,404
+8,176
| +2% | +$83K |
|
3396
Mercer International
MERC
$206M
| $5M | ﹤0.01% |
421,594
+1,686
| +0.4% | +$20K |
|
|
SNNA
3397
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| $4.99M | ﹤0.01% |
+224,314
| New | +$4.99M |
|
3398
SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
| $4.97M | ﹤0.01% |
102,159
| – | – |
|
|
TAX
3399
DELISTED
Liberty Tax, Inc. Class A
TAX
| $4.94M | ﹤0.01% |
343,181
+16,440
| +5% | +$237K |
|
|
CBAY
3400
DELISTED
Cymabay Therapeutics
CBAY
| $4.94M | ﹤0.01% |
613,220
+431,896
| +238% | +$3.48M |
|